This compound is a pharmaceutical intermediate featuring a complex polycyclic structure containing fluorine atoms, an ether linkage, and a sulfur-containing ring. It is primarily used in the manufacturing of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2136287-69-7
(R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Pharmaceutical intermediate for baloxavir marboxil
Baloxavir marboxil
active pharmaceutical ingredient
4-Chloro-3-(3-methoxypropoxy)-5-nitrobenzamide
pharmaceutical intermediate
2-Chloro-3-fluoronitrobenzene
Pharmaceutical intermediate
2-Chloro-3-fluoroaniline
Pharmaceutical intermediate for synthesis
2'-O-Methylguanosine
Pharmaceutical intermediate for modified RNA synthesis
Baloxavir
antiviral active pharmaceutical ingredient
(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-hexoxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione
DLJYUQAKCYNPSB-VPUSJEBWSA-N
CCCCCCOC1=C2C(=O)N3CCOC[C@H]3N(N2C=CC1=O)[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F